Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12903935 | 0.82 | GPR119 (0.55) | GPR119 | |
| SCHEMBL12835415 | 0.79 | GPR119 (0.48) | GPR119CYP2C9 | |
| SCHEMBL12835597 | 0.79 | GPR119 (0.49) | GPR119CYP2C9 | |
| SCHEMBL12904514 | 0.78 | GPR119 (0.49) | GPR119CYP2C9 | |
| SCHEMBL12904176 | 0.77 | GPR119 (0.47) | GPR119CYP2C9 | |
| SCHEMBL12903937 | 0.76 | GPR119 (0.50) | GPR119CYP2C9 | |
| SCHEMBL12835414 | 0.76 | RPS6KB1 (0.37) | GPR119 | |
| SCHEMBL12835891 | 0.75 | GPR119 (0.46) | GPR119CYP2C9 | |
| SCHEMBL390767 | 0.73 | GPR119 (0.68) | GPR119CYP2C9 | |
| Hydrochloric Acid SCHEMBL1244784 | 0.73 | GPR119 (0.67) | GPR119CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2292620-A2 | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prohylaxis and treatment of disorders related thereto | Arena Pharmaceuticals, Inc. (US) | 2011-03-09 | — | — | EP | disclosed |
| EP-2287166-A2 | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto | Arena Pharmaceuticals, Inc. (US) | 2011-02-23 | — | — | EP | disclosed |
| EP-2287165-A2 | Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto | Arena Pharmaceuticals, Inc. (US) | 2011-02-23 | — | — | EP | disclosed |